Antonio Gualberto
About Antonio Gualberto
Antonio Gualberto is the Vice President of External Innovation at BeiGene and has extensive experience in oncology R&D, precision therapeutics, and immunotherapy.
Title
Antonio Gualberto holds the position of Vice President, External Innovation at BeiGene. He is based in Cambridge, Massachusetts, United States.
Company
Currently, Antonio Gualberto works at BeiGene, a biotechnology company specializing in developing therapies for cancer treatment. He serves as Vice President, External Innovation and is based in Cambridge, Massachusetts, United States.
Previous Roles
Antonio's career includes notable positions such as Chief Medical Officer at SURGE Therapeutics, President of Research & Development at Exo Therapeutics, and Chief Medical Officer at H3 Biomedicine. He has also co-founded and served as CMO at Kura Oncology and worked as a consultant CMO at Wellspring Biosciences. His diverse roles have seen him working across different regions including London and La Jolla, California.
Education and Expertise
Antonio Gualberto has an extensive educational background, holding a Doctor of Medicine (MD) and a Doctor of Philosophy (PhD) in Clinical Pathology from Universidad de Sevilla. He was a MEC Fellow at Case Western Reserve University School of Medicine and a Fellow at both the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, and UCL. His expertise includes integrating genomics with clinical evidence and developing precision therapeutics and immunotherapy.
Background in Oncology
Antonio has 25 years of experience in Oncology R&D, having significant roles like Head of the Global Clinical Development Center - Oncology US at EMD Serono, Inc. His profound understanding and experience in oncology have made him a valuable asset in roles focused on innovative cancer therapy development.